Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 28 av 28 resultater
Tid
Selskap
Tittel
Sektor
Kategori
24 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis sera à San Francisco durant la JP Morgan Healthcare Conference de 2025
20103010 Biotechnology
Legal
24 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis Will Be In San Franscico During The 2025 JP Morgan Healthcare Conference
20103010 Biotechnology
Legal
23 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis showcased the OBA program in obesity at the 17th SCWD international congress
20103010 Biotechnology
Legal
23 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis a présenté le programme OBA dans l\'obésité lors du 17ème congrès international de la SCWD
20103010 Biotechnology
Legal
02 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis participe à la 17ème édition du congrès SCWD et organise un Obesity Investor Call
20103010 Biotechnology
Legal
02 Dec 2024
07:00 CET
BIOPHYTIS
Biophytis participates in the 17th SCWD Congress and hosts an Obesity Investor Call
20103010 Biotechnology
Legal
30 Sep 2024
23:00 CEST
BIOPHYTIS
Biophytis publie ses comptes semestriels et fait le point sur ses activités
20103010 Biotechnology
General meeting / Board Meeting
30 Sep 2024
23:00 CEST
BIOPHYTIS
Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
20103010 Biotechnology
General meeting / Board Meeting
22 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
20103010 Biotechnology
Other subject
22 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis déploie sa stratégie de partenariats et signe deux contrats avec des agents locaux en Asie
20103010 Biotechnology
Other subject
11 Jul 2024
07:01 CEST
BIOPHYTIS
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
20103010 Biotechnology
Other subject
11 Jul 2024
07:01 CEST
BIOPHYTIS
Biophytis obtient l’autorisation IND de la FDA pour démarrer son étude OBA de phase 2 dans l’obésité
20103010 Biotechnology
Other subject
01 Jul 2024
07:00 CEST
BIOPHYTIS
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
20103010 Biotechnology
Other subject
01 Jul 2024
07:00 CEST
BIOPHYTIS
Biophy(s a présenté les résultats de l\'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris
20103010 Biotechnology
Other subject
25 Jun 2024
23:00 CEST
BIOPHYTIS
RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
20103010 Biotechnology
Other subject
25 Jun 2024
23:00 CEST
BIOPHYTIS
RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024
20103010 Biotechnology
Other subject
20 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
20103010 Biotechnology
Other subject
20 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€
20103010 Biotechnology
Other subject
19 Jun 2024
23:00 CEST
BIOPHYTIS
Biophytis prolonge son contrat avec Atlas pour sécuriser le financement de ses activités
20103010 Biotechnology
Other subject
19 Jun 2024
23:00 CEST
BIOPHYTIS
Biophytis extends its contract with Atlas to secure financing for its business activities
20103010 Biotechnology
Other subject
12 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
20103010 Biotechnology
Other subject
12 Jun 2024
07:00 CEST
BIOPHYTIS
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
20103010 Biotechnology
Other subject
10 Jun 2024
08:18 CEST
BIOPHYTIS
Biophytis annonce le dépôt d\'une demande d\'IND auprès de la FDA pour son étude de phase 2 dans l\'obésité
20103010 Biotechnology
Other subject
10 Jun 2024
08:18 CEST
BIOPHYTIS
Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
20103010 Biotechnology
Other subject
07 Jun 2024
08:23 CEST
BIOPHYTIS
Combined General Meeting of June 24, 2024
20103010 Biotechnology
Other subject
07 Jun 2024
08:23 CEST
BIOPHYTIS
Assemblée générale mixte du 24 juin 2024
20103010 Biotechnology
Other subject
14 May 2024
07:00 CEST
BIOPHYTIS
Biophytis announces the design of its phase 2 OBA clinical study in obesity
20103010 Biotechnology
Other subject
14 May 2024
07:00 CEST
BIOPHYTIS
Biophytis annonce le design de son étude clinique de phase 2 OBA dans l\'obésité
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
DSP
Education
Academy
Stocks Education
Option education
Our Indices
Educational videos
News & Insights
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva